New drug tested for Tough-to-Treat autoimmune conditions
NCT ID NCT07229144
Summary
This early-stage study is testing the safety and side effects of an experimental drug called OM336 in people with active Sjogren's disease or inflammatory muscle disease. The trial will enroll 39 adults whose conditions haven't responded well to at least two previous treatments. Participants will receive increasing doses of OM336 injections to determine how the body handles the medication.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IDIOPATHIC INFLAMMATORY MYOPATHY (IIM) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.